2月10日，A股主要指数窄幅震荡整理，科创综指相对较强；港股早盘一度走高，随后涨幅有所收窄。 具体来看，沪指盘中在4100点上方窄幅震荡，科创综指相对较强，盘中一度涨超1%。截至收盘，沪指涨0.13%报4128.37点，深证成指微涨0.02%，创业板 指跌0.37%，科创综指涨0.31%，沪深北三市合计成交约2.12万亿元，较此前一日减少逾1400亿元。 A股市场超3100股飘绿，酿酒、食品饮料、零售等消费板块集体下挫，电力、有色等板块均走低；传媒板块全线爆发，短剧游戏、影视股表现亮眼，荣信 文化、中文在线、捷成股份等连续两日20%涨停，光线传媒（300251）亦大单封涨停；创新药概念拉升，广生堂涨超10%，万邦德涨停。值得注意的是， 长飞光纤今日再度涨停，股价突破200元大关，续创历史新高。 传媒板块盘中全线爆发，短剧游戏、影视股等表现亮眼。截至收盘，捷成股份、荣信文化、中文在线等连续两日20%涨停，读客文化、幸福蓝海、光线传 媒亦20%涨停，华策影视涨近18%，此外，还有欢瑞世纪、读者传媒、中国电影等约20股10%涨停。 | 代码 名称 | 涨幅% | 现价 | 不正失 | 兴价 | 卖价 | 总量 | ...

1. Report Industry Investment Rating - Not provided in the given content 2. Core Viewpoints of the Report - The report focuses on constructing multiple ETF portfolios, including macro industry, macro + momentum industry, core - satellite, and trinity style rotation portfolios, aiming to find better investment opportunities by combining macro factors, momentum factors, and style rotation [4][5]. - Different industries have different sensitivities to economic, liquidity, and credit factors. For example, traditional cycle industries are sensitive to the economy, TMT is sensitive to liquidity, and consumption is sensitive to credit [4]. 3. Summary According to Relevant Catalogs 3.1 ETF Portfolio Construction Methods 3.1.1 Based on Macro Method - Calculate macro - sensitivities of broad - based, industry - themed, and Smart Beta ETFs based on economic, liquidity, and credit variables. Combine with momentum indicators for complementary analysis [4]. - Traditional cycle industries are suitable for economic up - periods, TMT for weak - economy but loose - liquidity periods, and consumption for credit - expansion periods. State - owned enterprises and ESG - related themes have low sensitivities to liquidity and credit [4]. - Construct three ETF portfolios (macro industry, macro + momentum industry, and core - satellite) and adjust positions monthly [4]. 3.1.2 Trinity Style Rotation ETF Portfolio Construction - Build a medium - to - long - term style rotation model centered on macro - liquidity, and compare it with the CSI 300 index [5]. - Construct three types of models (growth/value rotation, market - cap, and quality models) by screening macro, fundamental, and market - sentiment factors. The model has 8 style - preference results [5]. - Select ETFs with high exposure to the target style, control industry exposure, and set allocation limits to get the final ETF allocation model [5]. 3.2 Macro Industry Portfolio - Select industry - themed ETFs with over 1 - year establishment and over 200 million current scale. Calculate sensitivity scores of economic, liquidity, and credit factors monthly, adjust scores according to the latest indicators, and sum them up. If liquidity and credit deviate significantly, remove the liquidity score. Select the top 6 industry - themed indices and corresponding largest - scale ETFs for equal - weight allocation [6][7]. - Currently, with falling economic leading indicators, loose liquidity, and tightened credit, the portfolio is biased towards TMT and consumption. The February positions are shown in Table 1 [8]. - The portfolio has large fluctuations and outperformed the benchmark significantly in January [11]. 3.3 Macro + Momentum Industry Portfolio - Combine macro and momentum methods to address the left - side nature of macro - based strategies (low win - rate but high odds). Use clustering to group industry - themed indices and select the highest - rising product in each group in the past 6 months for equal - weight allocation [12]. - The momentum - selected industries still have a high proportion of cyclical industries. The February positions are shown in Table 3 [16]. - The portfolio has performed well this year and outperformed the CSI 300 significantly in January [17]. 3.4 Core - Satellite Portfolio - Design a "core - satellite" portfolio with the CSI 300 as the core to address the high volatility and rapid industry rotation of industry - themed ETFs [19]. - Calculate macro - sensitivities for broad - based, industry - themed, and Smart Beta ETFs, construct three stock portfolios, and weight them at 50%, 30%, and 20% respectively [19]. - The current allocation of broad - based ETFs is biased towards the Sci - tech Innovation Board and the ChiNext. The portfolio has performed stably, outperforming the benchmark in most months except December, and had significant excess returns in January 2026 [23][24]. 3.5 Trinity Style Rotation ETF Portfolio - The model currently favors the small - cap growth - high - quality segment. The factor exposures and historical performance are shown in Table 7 [26]. - The February positions are shown in Table 9 [31]. - The portfolio has achieved certain excess returns, especially in some months such as August 2025 and January 2026 [29].

Market Overview - The Hong Kong stock market exhibited a "structural differentiation" trend on February 10, with a strong wait-and-see sentiment before the holiday. The Hang Seng Index rose by 0.58% to 27,183.15 points, the Hang Seng Tech Index increased by 0.62% to 5,451.03 points, the National Enterprises Index climbed by 0.81% to 9,242.75 points, and the Red Chip Index gained 0.27% to 4,407.29 points [1] Individual Stock Highlights - Evergrande Property saw a significant increase of 5.36% to 1.18 HKD, driven by news of potential bidders submitting updated offers for the company's assets, indicating progress in the liquidation process [2] - The stock of Geekplus Technology surged by 11.37% to 28.02 HKD following the launch of its Gino 1 warehouse robot, which is expected to accelerate the adoption of unmanned warehouses [3] - Yiteng Jiahe rose nearly 7% due to the completion of the first dosing in Phase II clinical trials for its ANGPTL3 siRNA drug EDP167 [4] - Bubble Mart received a favorable outlook from Macquarie, with a reiterated "outperform" rating, projecting global sales to exceed 400 million units by 2025 [5] Sector Performance - The AI and robotics sector emerged as a strong focus, with multiple stocks experiencing significant gains, including MiniMax-WP and Zhiyuan, which saw increases of 24% and 11%, respectively [3] - Pharmaceutical and technology hardware stocks also showed positive performance, with notable gains from companies like Singularity and Gree Medical, benefiting from favorable policy changes and strategic investments [4] Institutional Insights - Dongwu Securities noted that despite increased inflows from southbound funds, overall trading volume in the Hong Kong market has decreased, influenced by global tech stock capital expenditure concerns [6] - Analysts from Jianyin International indicated that the valuation recovery of Hong Kong stocks is nearly complete, shifting the investment logic from "valuation recovery" to "new productive forces" [6] - Analysts emphasized that the continuous inflow of southbound funds could enhance market sentiment and strengthen the pricing power of mainland funds in the Hong Kong market [6]

Market Overview - The A-share market experienced narrow fluctuations with mixed performance among the three major indices, where the Shanghai Composite Index rose by 0.13% and the ChiNext Index fell by 0.37% [2] - The media sector led the gains, particularly driven by the human-shaped robot concept, while the commercial aerospace concept declined [2] Sector Performance - The film and cinema sector surged by 11.31% in a single day, with related concepts such as Sora, short drama games, and cultural media also seeing significant increases [4][5] - Year-to-date performance shows the film and cinema sector up by 35.45%, short drama games up by 31.08%, and Sora concept up by 25.25% [5] AI Software Impact - The AI software sector emerged as a key focus, particularly with the recent buzz around ByteDance's new video generation model, Seedance 2.0, which has significant implications for AI multi-modal applications and video generation [6] - The model's breakthroughs are expected to lower production costs and technical barriers, enhancing efficiency in generating AI content [6] Market Sentiment and Trends - There is a notable trend of market participants seeking similarities in past performance, as seen with the DeepSeek index's significant rise last year, which has led to speculation about the potential for similar gains with the current "SD" concept [7][9] - The current market sentiment is influenced by the upcoming Chinese New Year, with investors looking for sectors that may gain traction during this period [9] Other Sector Highlights - The innovative drug sector showed strength, with a record transaction scale of $135.7 billion expected in 2025 for China's innovative drug license-out [14] - The PCB sector is anticipated to benefit from advancements in technology, particularly with applications in Nvidia and ASIC products [15] - The semiconductor equipment sector is projected to reach $791.7 billion in total sales by 2025, with a 26% growth expected in 2026 [16] - The humanoid robot sector remains active, with the launch of a new general-purpose robot platform that features advanced motion control capabilities [17]

Market Overview - The market showed slight differentiation today, with the Shanghai Composite Index closing up slightly while the ChiNext Index performed weaker. The total market turnover was 2.1 trillion, a decrease of over 100 billion compared to the previous trading day, with more stocks declining than rising [1] - The AI application sector saw a surge, with various sub-sectors such as film, short dramas, and multi-modal applications experiencing significant growth. The AI video generation model Seedance 2.0 from ByteDance gained traction during its testing phase [1] Sector Performance - The media sector, particularly film and digital media, attracted significant capital inflow, with leading stocks like Light Media and Sunshine Power seeing net inflows [3] - The biopharmaceutical sector also rose, led by innovative drug companies, with stocks like Wanbangde hitting the daily limit [1] - Conversely, retail and liquor stocks faced adjustments, with Hangzhou Jiebei hitting the daily limit down and Huangtai Liquor nearing the limit down [1] Key Stock Movements - The newly listed commercial aerospace stock, Electric Science and Technology Blue Sky, saw a dramatic increase of 750% on its first trading day, ultimately closing up nearly 600%, with a total market value exceeding 110 billion [1] Future Outlook - CITIC Securities indicated that the market is likely to experience moderate fluctuations due to the upcoming holiday, suggesting a consolidation phase [2] - Guoxin Securities noted that the current spring market may still have room for further development, recommending a strategy of holding stocks through the holiday [2][7] - Dongwu Securities highlighted that the week before the holiday is an optimal window for index positioning, with historical data suggesting a trend reversal typically begins in the last five trading days before the holiday [8]

Group 1 - The peak of overseas liquidity shock has passed, and "buy the dip" is an effective strategy according to China Merchants Securities [1] - The EPS expectations for the Hong Kong tech sector have been continuously revised down since September, but have recently stabilized, indicating that current stock prices reflect the market's phased downward adjustment of earnings [1] - The relative valuation of the Hong Kong tech sector has reached historical lows, with the AH premium nearing historical lows, and the current regulatory and economic development environment is significantly better than in previous years, suggesting the sector is undervalued [1] Group 2 - There are continuous catalysts in the industry, with major companies like Tencent and Alibaba actively promoting large models during the Spring Festival, indicating smooth progress on the industrial front [1] - The Hong Kong Tech ETF (513020) tracks the Hong Kong Stock Connect Technology Index (931573), covering core assets in Hong Kong's tech sector, reflecting the diversified characteristics of the tech industry [1] - The Hong Kong Stock Connect Technology Index has outperformed the Hang Seng Tech Index, with a cumulative return of 224.25% from the end of 2014 to the end of 2025, exceeding the Hang Seng Tech Index's return of 83.87% by over 140%, indicating long-term outperformance against similar indices [1]

从基本面看，创新药业绩预告验证产业景气。信达生物、荣昌生物和君实生物预告2025年收入约 110/32.5/25亿元，分别同比增长45%/89%/31.8% 国金证券认为，2-3月有望迎来创新药企业的业绩披露窗口，多家药企有望迎来减亏或扭亏，同时预计 2026年更多创新药企业有望扭亏并大幅释放利润；展望全年，AACR（4月）、ASCO（5月）、ESMO （10月）等学术会议上国产创新药有望进一步带来临床数据的兑现；整体上，创新药前期回调较为充 分，向上产业趋势明确，催化近期密集，继续看好板块投资机会。 港股创新药上涨，截至发稿，港股通创新药ETF易方达(159316)涨2.89%，港股通医药ETF易方达 (513200)涨2.33%。 板块反弹主要受BD交易密集落地、预告业绩高增及流动性改善三重利好驱动。 创新药重磅BD频出：石药集团×阿斯利康：1月30日达成185亿美元合作（首付12亿美元），创中国药企 BD纪录； 信达生物×礼来：2月8日达成88.5亿美元合作（首付3.5亿美元），采用"端到端共研"模式； 2026年以来创新药BD首付款规模已超25年全年最高单季度水平，总交易金额达332.8亿美元（占25 ...

Group 1 - The core viewpoint of the news highlights a rebound in innovative pharmaceuticals, with the Guotai Innovation Drug ETF (589720) rising over 2% and attracting nearly 500 million yuan in funds over the past 10 days, currently leading its peers with a total size exceeding 1.5 billion yuan [1] - Recent industry dynamics focus on multinational collaborations and domestic innovations, exemplified by the strategic partnership between Innovent Biologics and Eli Lilly to advance global R&D in oncology and immunology, with Innovent receiving an upfront payment of 350 million USD and potential milestone payments of up to 8.5 billion USD [1] - Additionally, Carl Zeiss announced the launch of its Greater China headquarters project in Shanghai, aimed at integrating and upgrading its core functions in management, R&D, and production to strengthen its innovation network in China [1] Group 2 - Bohai Securities noted that at the 2026 JPM Healthcare Conference, numerous Chinese pharmaceutical companies showcased their latest research achievements, and there has been a surge in large-scale business development (BD) activities, indicating active collaboration with multinational corporations (MNCs) [2] - The report suggests monitoring companies that may experience a bottoming out of performance as earnings forecasts are disclosed, while also highlighting the rapid development of brain-computer interfaces and AI applications, which are expected to benefit consumer-oriented companies amid domestic demand recovery [2] - The industry faces several risks, including geopolitical tensions, product development failures, expanded centralized procurement leading to price pressures, intense competition causing price declines, and significant increases in raw material costs [2]

Group 1 - The core viewpoint of the news highlights significant advancements in the biotech sector, particularly in the collaboration between Innovent Biologics and Eli Lilly, which focuses on new drug development in oncology and immunology, with a deal size exceeding expectations [1] - The collaboration employs a "China PoC + global development" model, leveraging Innovent's efficient clinical validation capabilities in China while utilizing Eli Lilly's global commercialization network to mitigate risks, marking a key step in the globalization of Chinese innovative pharmaceutical companies [1] - The assets involved in the collaboration, such as IBI363 and IBI343, have entered global multi-center Phase III clinical trials, with a combined potential market space of $60 billion [1] Group 2 - The ADC commercialization process is accelerating, with 20 ADC drugs approved globally, six of which have consistently been in the "billion-dollar club" for two years; approximately 60 are in Phase III clinical trials or awaiting market approval [2] - Local companies are increasingly gaining advantages due to their self-commercialization capabilities, as seen with Rongchang Biologics transitioning from outsourcing to in-house production, and Keren Biotechnology and Baillie Tianheng accelerating the establishment of their own production bases [2] - The Hong Kong Innovation Drug ETF has seen a strong performance, with a 3.10% increase as of February 10, 2026, and a total scale of 25.98 billion yuan, indicating a positive trend in investment within the sector [2]

Market Overview - The A-share market is experiencing narrow fluctuations, with a focus on AI applications, while traditional sectors like liquor and non-ferrous metals are facing declines, impacting major indices [1] - As of the midday break, the Shanghai Composite Index is at 4122.34 points, down 0.02%, the Shenzhen Component Index is down 0.02%, and the ChiNext Index is down 0.14%, while the Sci-Tech Innovation Board Index is up 0.19% [1] AI Application Sector - The AI application sector has seen significant activity, particularly in the "AI + Film" direction, leading to a surge in stock prices, with over ten film-related stocks hitting the daily limit [2] - Notable stocks include: - Jiecheng Co., Ltd. (300182) and Zhongwen Online (300364) both achieving a 20% increase for two consecutive days - Industry leader Light Media (300251) also rising by 20% [2][3] Seedance 2.0 Impact - The recent internal testing of ByteDance's Seedance 2.0 video model has sparked widespread discussion, showcasing its ability to create high-quality videos from text or images in just 60 seconds [4] - Analysts believe that Seedance 2.0 represents a breakthrough in AI capabilities, potentially revolutionizing the production of short content like AI dramas and significantly reducing costs and increasing efficiency in production [4] Innovative Drug Sector - The innovative drug sector is experiencing a revival after a period of stagnation, with Wanbangde (002082) hitting the daily limit and Guangshengtang (300436) rising over 8% [6] - The National Medical Products Administration has announced that by 2025, China's pharmaceutical industry will accelerate its internationalization, with innovative drug overseas licensing transactions expected to exceed $130 billion, marking a shift from a "generic drug production powerhouse" to an "innovative drug exporting powerhouse" [8]